Novel long non-coding RNA lncAMPC downregulates PTEN via miR-214 to promote nasopharyngeal carcinoma progression

被引:0
|
作者
Xianqing Li
Shunlin Ouyang
机构
[1] The Third Affiliated Hospital of Guangzhou Medical University,
来源
关键词
LncAMPC; Nasopharyngeal carcinoma; PTEN; miR-214; Cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
Long non-coding RNAs (lncRNAs) are a type of non-coding RNAs with transcript lengths exceeding 200 nt. lncRNAs suppress or promote cancer mainly by regulating gene expression. The aim of this study was to explore the role of lncRNAs activated in metastatic PCa (lncAMPC) in nasopharyngeal carcinoma (NPC). Total RNAs were isolated from NPC and adjacent non-tumor tissues from 60 NPC patients and subjected to RT-qPCR to analyze differential expression of lncAMPC and miR-214. The roles of lncAMPC and miR-214 in regulating PTEN expression were analyzed using RT-qPCR and Western blot. Cell proliferation was analyzed using the BrdU assay. The results showed that lncAMPC was overexpressed in NPC tissues and was localized in both nuclei and cytoplasms of NPC cells. MiR-214 was positively correlated with lncAMPC. LncAMPC overexpression upregulated miR-214 and indirectly downregulated PTEN via miR-214. BrdU incorporation assay showed that lncAMPC and miR-214 overexpression increased cell proliferation. PTEN overexpression completely reversed the promoting effects of lncAMPC and miR-214 overexpression on cell proliferation. Therefore, lncAMPC might downregulate PTEN via miR-214 to increase NPC cell proliferation.
引用
收藏
页码:805 / 814
页数:9
相关论文
共 50 条
  • [21] Long non-coding RNA RGMB-AS1 represses nasopharyngeal carcinoma progression via binding to forkhead box A1
    Zhang, Tian
    Jin, Ying
    Luo, Xiangmei
    BIOENGINEERED, 2022, 13 (03) : 5564 - 5580
  • [22] Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression
    Zhu, Hongyu
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2020, 138
  • [23] An investigation on long non-coding RNA PVT1 / miR-214 / NF-κB and long non-coding RNA MALAT1 / miR-9 / NF-κB in individuals diagnosed with type 2 diabetes mellitus
    Aghaei-Zarch, Seyed Mohsen
    Mehrjardi, Mohammad Yahya Vahidi
    Mazloumi, Zeinab
    Motallebi, Marzieh
    Soleimani, Shahrzad
    Tavirani, Mostafa Rezaei
    Sheikhpour, Mojgan
    Aghamohammadi, Nicka
    Movafagh, Abolfazl
    HUMAN GENE, 2024, 39
  • [24] Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126
    Huang, Tao
    Wang, Xiao
    Yang, Xiaokun
    Ji, Jianlei
    Wang, Qinghai
    Yue, Xuan
    Dong, Zheng
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7340 - 7347
  • [25] Long Non-coding RNA KTN1-AS1 Targets miR-505 to Promote Glioblastoma Progression
    Guo, Kai
    Fang, Lingling
    Li, Mingjian
    Li, Aizheng
    Liu, Na
    BEHAVIOURAL NEUROLOGY, 2023, 2023
  • [26] The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
    C Cao
    T Zhang
    D Zhang
    L Xie
    X Zou
    L Lei
    D Wu
    L Liu
    Oncogene, 2017, 36 : 1112 - 1122
  • [27] The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
    Cao, C.
    Zhang, T.
    Zhang, D.
    Xie, L.
    Zou, X.
    Lei, L.
    Wu, D.
    Liu, L.
    ONCOGENE, 2017, 36 (08) : 1112 - 1122
  • [28] Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma
    Dong, Yameng
    Yuan, Haozhan
    Jin, Guangyu
    ONCOLOGY LETTERS, 2018, 16 (02) : 2750 - 2756
  • [29] Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma
    Li, Li
    Gu, Miao
    You, Bo
    Shi, Si
    Shan, Ying
    Bao, Lili
    You, Yiwen
    CANCER SCIENCE, 2016, 107 (09) : 1215 - 1222
  • [30] Long non-coding RNA DANCR promotes nasopharyngeal carcinoma cell proliferation and migration
    Hao, Yalin
    Zhao, Hui
    Jin, Xiaojie
    He, Ping
    Zhang, Jiafeng
    Dong, Qiongna
    Shi, Weiwei
    Zhao, Miaomiao
    MOLECULAR MEDICINE REPORTS, 2019, 19 (04) : 2883 - 2889